Lipocine Inc (LPCN)
4.80
-0.31
(-6.07%)
USD |
NASDAQ |
Apr 23, 16:00
4.72
-0.08
(-1.67%)
After-Hours: 19:24
Lipocine Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -479.6% |
| March 31, 2022 | |
| December 31, 2021 | 85.99% |
| September 30, 2021 | -4.20K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -938.5% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -221.8% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-4.20K%
Minimum
Sep 2021
85.99%
Maximum
Dec 2021
-1.38K%
Average
-709.0%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | -- |
| Eliem Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -58.82% |
| Return on Assets | -54.58% |
| Return on Invested Capital | -58.82% |
| Profit Margin (Quarterly) | -1.06K% |
| Operating Margin (Quarterly) | -1.20K% |
| Return on Net Operating Assets | -3.00K% |